Jefferies analyst Vanessa Jeffriess maintained a Buy rating on Judges Scientific today and set a price target of p9,365.00.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Vanessa Jeffriess’s rating is based on several factors influencing Judges Scientific’s stock. Despite a reduction in the FY25F EPS guidance, which is 10% below Jefferies’ estimates, there was a notable 15% year-over-year increase in 1H25 EPS driven by Geotek. This indicates a positive performance in certain areas, although the overall guidance has been adjusted downwards.
Jeffriess acknowledges the challenges ahead, particularly in the US market and specific business issues that could impact performance. However, she sees potential for cost-cutting measures and believes in the longer-term growth story of Judges Scientific. While the immediate outlook may be challenging, especially with the lack of mergers and acquisitions to offset difficulties, the potential for future opportunities and strategic adjustments supports a Buy rating.
In another report released on July 8, TR | OpenAI – 4o also reiterated a Buy rating on the stock with a p94.00 price target.